Threaticon
Toggle sidebar

You're viewing a limited, public preview. Log in for full access.

Log in User Guide
Log in Get started
Indicators Public and Private Medical Community Targeted by Threat Actor Pursuing Artificial Intelligence, Cyber, Medical, and National Defense Research

58bb25777e0aa86bcd2125101e0bca4e8732b03d91bd8d2f205b446a2a8d5c86

TLP:CLEAR
Active

SHA-256 Hash

Description

A sophisticated espionage campaign attributed to UNC6508, a China-nexus threat actor, targeted North American academic, medical, and military research institutions for over a year. The adversary exploited REDCap servers, deployed custom INFINITERED malware to harvest credentials, and maintained persistent access through trojanized legitimate files that survived software upgrades. After remaining undetected for more than a year, the threat actor pivoted to administrative accounts and created malicious content compliance rules to silently exfiltrate emails containing defense intelligence, Indo-Pacific command operations, artificial intelligence research, uncrewed vehicle systems, cyber programs, and medical research data. The operation employed sophisticated techniques including obfuscation networks routing through US-based infrastructure, compromised routers, and dedicated exfiltration accounts, demonstrating advanced operational security aligned with strategic intelligence collection r...

Sightings (0)

No sightings recorded yet

Details

Name / Label
Public and Private Medical Community Targeted by Threat Actor Pursuing Artificial Intelligence, Cyber, Medical, and National Defense Research
Pattern Type
STIX
Confidence
75%
Valid From
Jul 15, 2026 20:00
Total Sightings
0
Added
Jul 15, 2026
No notes yet. Click "Add Note" to create the first analysis note.
No opinions yet. Be the first to assess this intelligence.

Record Sighting

Record an observation of 58bb25777e0aa86bcd2125101e0bca4e8732b03d91bd8d2f205b446a2a8d5c86

Sighting Type
Source
Comment
Leaving Threaticon

This link opens an external site that isn't part of the platform.